Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals

April 29, 2024

https://www.globenewswire.com/news-release/2024/04/29/2871280/0/en/Lonnel-Coats-Retires-as-Chief-Executive-Officer-and-Board-Member-of-Lexicon-Pharmaceuticals.html

THE WOODLANDS, Texas, April 29, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX) today announced that Lonnel Coats has provided notice of his retirement as chief executive officer and as a member of its board of directors, in each case effective July 7, 2024, his 10th anniversary with the company. The board of directors has initiated a search for a new chief executive officer which will consider both internal and external candidates.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.